Taxotere MDL News
Taxotere Plaintiffs Request Some Cases Be Sent Back to State Courts
July 20, 2017
Some of the plaintiffs in a federal Multi-District Litigation (MDL) case concerning the allegedly harmful effects of the chemotherapy drug Taxotere have requested that their cases be heard in state courts in California, Delaware, and Missouri, rather than in a federal trial.
The issue is largely a procedural matter that nevertheless refocuses attention on a trial that is already being closely watched.
Taxotere, an intravenous cancer drug that is most often used to treat breast cancer, prostate cancer, and certain types of lung cancer, has been linked to numerous cases of permanent hair loss in women. Many chemotherapy drugs cause temporary hair loss; Taxotere is the subject of many claims of permanent hair loss.
Also at issue in the Taxotere MDL are questions about whether its maker, Sanofi-Aventis, promoted and marketed it too aggressively, and whether the company was aware of its side effects before releasing the drug onto the marketplace.
The Taxotere MDL consists of more than 1100 individual lawsuits against Sanofi-Aventis.
If you have experienced permanent hair loss as a result of taking Taxotere, you may be entitled to be part of this or another legal action. Contact TheLawFirm.com to find out how we can help you.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!